Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:22

RNS Number : 0199K
Softcat PLC
05 April 2018
 

Softcat plc (the "Company")

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities

 

 

The following notification relates to the award of nil-cost options to person discharging managerial responsibilities ("PDMR") on 4 April 2018 under the Softcat plc Long Term Incentive Plan ("LTIP").  

 

Softcat plc Long Term Incentive Plan

 

On 4 April 2018, an award of nil-cost options to acquire 66,864 shares was made to Graeme Watt, a director and PDMR. The number of shares over which the nil-cost option was awarded has been calculated by reference to the closing middle market quotation of the ordinary shares derived from the Daily Official List on the dealing day preceding the date of grant (6.73 pence). The award will vest subject to the performance conditions outlined below.

 

 

Performance Conditions and Vesting of Awards

 

These nil-cost options are subject to the rules of the LTIP and will vest depending on performance against Total Shareholder Return ("TSR") and Earnings per Share ("EPS") targets as measured over a three year performance period.

 

50% of the Award will be subject to the Company's relative TSR performance against the FTSE 250 (excluding real estate and investment trusts):

 

TSR performance % of Award vesting

Below median Nil

At median 30%

Upper quartile or above 100%

 

50% of the Award will be subject to the Company's EPS for FY 2020:

 

EPS Growth % of Award vesting

Less than 23.7 pence Nil

23.7 pence 20%

26.9 pence or above 100%

 

There will be straight line vesting between the points as outlined above.

 

The normal date of vesting for the nil-cost options outlined above will be 4 April 2021 and the last date for exercise will be 3 April 2028, with dividend equivalents payable in respect of the vesting of nil-cost options in accordance with the rules of the LTIP.

 

For further information on the LTIP, please refer to the Company's Annual Report and Accounts.

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Graeme Watt

 

2.

Reason for the notification

a)

Position / status

Chief Executive

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Softcat plc

b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of £0.0005 each

 

 

ISIN: GB00BYZDVK82

b)

Nature of the transaction

Grant of nil cost option over Ordinary Shares of £0.0005 each under the Softcat plc Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

0.00

66,864

d)

Aggregated information

Aggregated volume

Price

 

N/A

e)

Date of the transaction

 

2018-04-04

f)

Place of the transaction

 

Outside a trading venue

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZMGGDKKGGRZM
Date   Source Headline
22nd Nov 20227:00 amRNSQ1 2023 Trading Update
14th Nov 202210:43 amRNSBlock listing Interim Review
9th Nov 20222:03 pmRNSDirector/PDMR Shareholding
3rd Nov 202210:59 amRNSAnnual Financial Report & Notice of AGM
25th Oct 20227:00 amRNSFinal Results
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:35 pmRNSPrice Monitoring Extension
14th Oct 20229:00 amRNSNotice of Results
11th Oct 202211:16 amRNSDirector/PDMR Shareholding
9th Sep 202210:30 amRNSDirector/PDMR Shareholding
1st Sep 202211:00 amRNSTotal Voting Rights
9th Aug 202211:16 amRNSDirector/PDMR Shareholding
1st Aug 202211:13 amRNSTotal Voting Rights
12th Jul 20227:00 amRNS2023 Board Succession Planning
11th Jul 202210:20 amRNSDirector/PDMR Shareholding
1st Jul 202211:47 amRNSTotal Voting Rights
8th Jun 20229:28 amRNSDirector/PDMR Shareholding
1st Jun 20225:10 pmRNSTotal Voting Rights
25th May 20227:00 amRNSQ3 2022 Trading Update
13th May 202210:56 amRNSBlock listing Interim Review
11th May 202210:50 amRNSDirector/PDMR Shareholding
10th May 20229:13 amRNSDirector/PDMR Shareholding
27th Apr 20229:41 amRNSDirector Declaration
11th Apr 202211:18 amRNSDirector/PDMR Shareholding
1st Apr 20222:30 pmRNSTotal Voting Rights
22nd Mar 20227:00 amRNSAppointment of Non-Executive Director
22nd Mar 20227:00 amRNSHalf-year Report
10th Mar 202212:17 pmRNSDirector/PDMR Shareholding
22nd Feb 20229:00 amRNSNotice of Results
9th Feb 202210:47 amRNSDirector/PDMR Shareholding
1st Feb 20223:03 pmRNSTotal Voting Rights
11th Jan 202211:04 amRNSDirector/PDMR Shareholding
5th Jan 20221:04 pmRNSTotal Voting Rights
15th Dec 20213:42 pmRNSResult of AGM
10th Dec 20219:00 amRNSSoftcat's 2021 AGM: COVID-19 Update
9th Dec 202112:26 pmRNSDirector/PDMR Shareholding
2nd Dec 20213:49 pmRNSDirector/PDMR Shareholding
2nd Dec 20213:45 pmRNSDirector/PDMR Shareholding
2nd Dec 20213:32 pmRNSDirector/PDMR Shareholding
1st Dec 20213:34 pmRNSTotal Voting Rights
29th Nov 20213:55 pmRNSDirector/PDMR Shareholding
29th Nov 20213:39 pmRNSDirector/PDMR Shareholding
26th Nov 202112:47 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSQ1 2022 Trading Update
16th Nov 20212:46 pmRNSBlock listing Interim Review
11th Nov 202110:17 amRNSAnnual Financial Report & Notice of AGM
10th Nov 202110:18 amRNSDirector/PDMR Shareholding
1st Nov 20214:05 pmRNSTotal Voting Rights
26th Oct 20217:00 amRNSFinal Results
8th Oct 20215:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.